BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27300512)

  • 21. Construction of a CXCL12-KDEL fusion gene to inhibit head and neck squamous cell carcinoma metastasis by intracellular sequestration of CXCR4.
    Zhang W; Wang X; Yue K; Liu S; Liu X
    Biomed Res Int; 2015; 2015():195828. PubMed ID: 25866764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between chemokine axis CXCL12-CXCR4 and epithelial ovarian cancer].
    Guo Q; Wu XH; Lü YP; Yang B; Xu F; Zhang SJ
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(21):1677-80. PubMed ID: 24125682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer.
    Yang P; Hu Y; Zhou Q
    Curr Med Chem; 2020; 27(33):5543-5561. PubMed ID: 31724498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion.
    Lv Z; Yang D; Li J; Hu M; Luo M; Zhan X; Song P; Liu C; Bai H; Li B; Yang Y; Chen Y; Shi Q; Weng Y
    Mol Cells; 2013 Aug; 36(2):119-26. PubMed ID: 23807047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
    Wang J; Loberg R; Taichman RS
    Cancer Metastasis Rev; 2006 Dec; 25(4):573-87. PubMed ID: 17165132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation.
    Lee Y; Kim JM; Lee EJ
    J Endocrinol; 2008 Nov; 199(2):191-9. PubMed ID: 18753332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model.
    Shanmugam MK; Manu KA; Ong TH; Ramachandran L; Surana R; Bist P; Lim LH; Kumar AP; Hui KM; Sethi G
    Int J Cancer; 2011 Oct; 129(7):1552-63. PubMed ID: 21480220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model.
    Tulotta C; Stefanescu C; Beletkaia E; Bussmann J; Tarbashevich K; Schmidt T; Snaar-Jagalska BE
    Dis Model Mech; 2016 Feb; 9(2):141-53. PubMed ID: 26744352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling.
    Masuda T; Endo M; Yamamoto Y; Odagiri H; Kadomatsu T; Nakamura T; Tanoue H; Ito H; Yugami M; Miyata K; Morinaga J; Horiguchi H; Motokawa I; Terada K; Morioka MS; Manabe I; Iwase H; Mizuta H; Oike Y
    Sci Rep; 2015 Mar; 5():9170. PubMed ID: 25773070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlations of chemokine CXCL12 and its receptor to tumor metastasis].
    Jiang YP; Wu XH
    Ai Zheng; 2007 Feb; 26(2):220-4. PubMed ID: 17298758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.
    Wendt MK; Cooper AN; Dwinell MB
    Oncogene; 2008 Feb; 27(10):1461-71. PubMed ID: 17724466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
    Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
    Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stromal cell-derived factor-1α and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells.
    Shin HN; Moon HH; Ku JL
    Int J Mol Med; 2012 Dec; 30(6):1537-43. PubMed ID: 23023114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
    Zhao S; Wang J; Qin C
    J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases.
    Gil M; Seshadri M; Komorowski MP; Abrams SI; Kozbor D
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):E1291-300. PubMed ID: 23509246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
    Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
    Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion.
    Yu FX; Hu WJ; He B; Zheng YH; Zhang QY; Chen L
    World J Surg Oncol; 2015 Feb; 13():52. PubMed ID: 25890096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidating a key component of cancer metastasis: CXCL12 (SDF-1α) binding to CXCR4.
    Tamamis P; Floudas CA
    J Chem Inf Model; 2014 Apr; 54(4):1174-88. PubMed ID: 24660779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
    Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
    J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteotropism of neuroendocrine tumors: role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro.
    Cives M; Quaresmini D; Rizzo FM; Felici C; D'Oronzo S; Simone V; Silvestris F
    Oncotarget; 2017 Apr; 8(14):22534-22549. PubMed ID: 28186979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.